{
    "clinical_study": {
        "@rank": "80703", 
        "arm_group": {
            "arm_group_label": "Physician Readers", 
            "arm_group_type": "Experimental", 
            "description": "Physician readers will interpret 60 Amyvid scans using qualitative analysis followed by the use of quantitation. No subjects will be exposed to florbetapir (18F) as part of this study."
        }, 
        "brief_summary": {
            "textblock": "This study is designed to validate the Japanese electronic florbetapir (18F) interpretation\n      training program intended for post-approval implementation in Japan."
        }, 
        "brief_title": "Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Alzheimer's Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Japanese Society of Nuclear Medicine (JSNM) Positron Emission Tomography (PET)\n             Certified Nuclear Medicine Physician\n\n          -  Minimal hands-on experience and no formal training in the visual interpretation of\n             florbetapir (18F) brain PET scans\n\n          -  Minimal hands-on experience and no formal training in the quantitation of florbetapir\n             (18F) brain PET scans\n\n        Exclusion Criteria:\n\n          -  Prior hands-on experience or formal training in the visual interpretation and/or\n             quantitation of florbetapir (18F) PET scans"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029547", 
            "org_study_id": "18F-AV-45-JPT01"
        }, 
        "intervention": {
            "arm_group_label": "Physician Readers", 
            "description": "No Florbetapir (18F) will be administered in this study.", 
            "intervention_name": "Florbetapir (18F)", 
            "intervention_type": "Drug", 
            "other_name": [
                "Florbetapir F 18", 
                "florbetapir", 
                "Amyvid", 
                "18F-AV-45"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "March 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tokyo", 
                    "country": "Japan", 
                    "zip": "100-0005"
                }, 
                "name": "Research Site"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Computer-Based Training to Educate Japanese Physicians in the Methods of Interpreting Florbetapir (18F) PET Scans", 
        "overall_contact": {
            "email": "clinicaloperations@avidrp.com", 
            "last_name": "Avid Clinical Operations", 
            "phone": "215-298-0700"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Measure of agreement among readers using a binary visual read method (amyloid positive/negative) calculated using Fleiss' kappa. All scans were read in a blinded fashion without access to clinical information.", 
                "measure": "Inter Rater Reliability", 
                "safety_issue": "No", 
                "time_frame": "Scan acquired 50-60 minutes post injection"
            }, 
            {
                "description": "Individual reader scan results will be compared to the expert panel's consensus rating for each scan.", 
                "measure": "Percent Agreement with Expert Panel", 
                "safety_issue": "No", 
                "time_frame": "Scan acquired 50-60 minutes post-injection"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029547"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluate the percent change in inter reader reliability after implementation of quantitation analysis.", 
                "measure": "Change in inter reader reliability after application of quantitation software", 
                "safety_issue": "No", 
                "time_frame": "Scan acquired 50-60 minutes post injection"
            }, 
            {
                "description": "The percent change in individual reader agreement with the expert panel's consensus rating will determined after implementation of quantitation analysis.", 
                "measure": "Change in agreement with expert panel", 
                "safety_issue": "No", 
                "time_frame": "Scan acquired 50-60 minutes post-injection"
            }
        ], 
        "source": "Avid Radiopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Avid Radiopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}